nad has been researched along with alpha-synuclein in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DR; Davies, P; Moualla, D | 1 |
| Barrientos, A; Liu, J; Ocampo, A | 1 |
| Bubacco, L; Girotto, S; Gratton, E; Jahid, S; Plotegher, N; Stringari, C; Veronesi, M | 1 |
| Abramov, AY; Angelova, PR; Buchman, VL; Gandhi, S; Ludtmann, MH; Ninkina, NN | 1 |
| Kráľová Trančíková, A; Pokusa, M | 1 |
| Tan, EK; Zhou, ZD | 1 |
| Gentry, MS; Macedo, JKA; Ostrakhovitch, EA; Quintero, JE; Song, ES; van Horne, C; Yamasaki, TR | 1 |
| Facey, PD; Hirth, F; Kocinaj, A; Parsons, AE; Parsons, RB; Prendergast, SA; Ruiz Pulido, G | 1 |
1 review(s) available for nad and alpha-synuclein
| Article | Year |
|---|---|
Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
Topics: alpha-Synuclein; Humans; Mitochondria; NAD; Parkinson Disease; Sirtuin 3 | 2020 |
7 other study(ies) available for nad and alpha-synuclein
| Article | Year |
|---|---|
Alpha-synuclein is a cellular ferrireductase.
Topics: alpha-Synuclein; Cell Line; Copper; FMN Reductase; Humans; Iron; Kinetics; Lewy Body Disease; NAD; Neurons; Parkinson Disease | 2011 |
NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins.
Topics: alpha-Synuclein; Gene Expression; Histone Deacetylases; Mitochondria; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Oxidative Phosphorylation; Peptides; Protein Folding; Saccharomyces cerevisiae; Wallerian Degeneration | 2013 |
NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cells.
Topics: alpha-Synuclein; Fluorescence; HEK293 Cells; Humans; Lewy Bodies; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Microscopy, Electron, Transmission; Models, Biological; NAD; Parkinson Disease; Protein Aggregates; Protein Binding; Spectrometry, Fluorescence | 2015 |
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase.
Topics: Adenosine Triphosphate; alpha-Synuclein; Animals; Astrocytes; Brain; Cells, Cultured; Energy Metabolism; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Proton-Translocating ATPases; NAD; Oxygen Consumption; Unfolded Protein Response | 2016 |
FLIM analysis of intracellular markers associated with the development of Parkinson's disease in cellular model.
Topics: alpha-Synuclein; Biomarkers; Cell Line, Tumor; Humans; Inclusion Bodies; Intracellular Fluid; Membrane Potential, Mitochondrial; Mitochondria; NAD; Optical Imaging; Parkinson Disease | 2018 |
Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
Topics: Aged; alpha-Synuclein; Biomarkers; Diagnosis, Differential; Essential Tremor; Female; Humans; Male; Middle Aged; NAD; Nicotinamide Phosphoribosyltransferase; Parkinson Disease; Pentose Phosphate Pathway | 2022 |
Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Topics: alpha-Synuclein; Dopaminergic Neurons; Humans; NAD; Neurites; Neuroblastoma; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Synucleinopathies | 2022 |